Serum Amyloid P Component Bound to Gram-Negative Bacteria Prevents Lipopolysaccharide-Mediated Classical Pathway Complement Activation

Documenti analoghi

• Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS
  di: de Haas, Carla J. C., et al.
  Pubblicazione: (1999)
• Serum Amyloid P Component Prevents High-Density Lipoprotein-Mediated Neutralization of Lipopolysaccharide
  di: de Haas, Carla J. C., et al.
  Pubblicazione: (2000)
• Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation
  di: Braem, Steven G.E., et al.
  Pubblicazione: (2015)
• Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide
  di: Sprong, Tom, et al.
  Pubblicazione: (2004)
• Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications
  di: Laarman, Alexander, et al.
  Pubblicazione: (2010)